ATG5 Human (+)-Tetrandrine increases expression EXP 6480464 tetrandrine results in increased expression of ATG5 protein CTD PMID:26822499 ATG5 Human (+)-Tetrandrine decreases expression EXP 6480464 tetrandrine results in decreased expression of ATG5 protein CTD PMID:25266202 ATG5 Human (-)-citrinin increases expression ISO Atg5 (Mus musculus) 6480464 Citrinin results in increased expression of ATG5 mRNA CTD PMID:22771370 ATG5 Human (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATG5 mRNA and TFEB protein affects the reaction [epigallocatechin gallate results in increased expression of ATG5 protein] CTD PMID:22079256 and PMID:39313106 ATG5 Human (-)-epigallocatechin 3-gallate increases expression EXP 6480464 epigallocatechin gallate results in increased expression of ATG5 protein CTD PMID:39313106 ATG5 Human 1,2-dimethylhydrazine decreases expression ISO Atg5 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of ATG5 mRNA CTD PMID:22206623 ATG5 Human 1,2-dimethylhydrazine multiple interactions ISO Atg5 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATG5 mRNA CTD PMID:22206623 ATG5 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Atg5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ATG5 mRNA CTD PMID:21570461 ATG5 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Atg5 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of ATG5 mRNA CTD PMID:33387578 ATG5 Human 2-(tert-butylimino)-5-phenyl-3-(propan-2-yl)-1,3,5-thiadiazinan-4-one increases expression EXP 6480464 buprofezin results in increased expression of ATG5 mRNA CTD PMID:36287832 ATG5 Human 2-hydroxyethyl methacrylate increases expression EXP 6480464 hydroxyethyl methacrylate results in increased expression of ATG5 protein CTD PMID:28184909 ATG5 Human 2-hydroxyethyl methacrylate multiple interactions EXP 6480464 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [hydroxyethyl methacrylate results in increased expression of ATG5 protein] more ... CTD PMID:28184909 ATG5 Human 2-hydroxypropanoic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of ATG5 mRNA CTD PMID:30851411 ATG5 Human 3,3',5-triiodo-L-thyronine affects response to substance ISO Atg5 (Mus musculus) 6480464 ATG5 protein affects the susceptibility to Triiodothyronine CTD PMID:30209975 ATG5 Human 3,3',5-triiodo-L-thyronine increases expression ISO Atg5 (Mus musculus) 6480464 Triiodothyronine results in increased expression of ATG5 mRNA and Triiodothyronine results in increased expression of ATG5 protein CTD PMID:30209975 ATG5 Human 3-chloropropane-1,2-diol increases expression ISO Atg5 (Rattus norvegicus) 6480464 alpha-Chlorohydrin results in increased expression of ATG5 protein CTD PMID:34915118 ATG5 Human 3-hydroxybutyric acid increases abundance EXP 6480464 ATG5 protein results in increased abundance of 3-Hydroxybutyric Acid CTD PMID:25943029 ATG5 Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ATG5 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ATG5 mRNA CTD PMID:28628672 ATG5 Human 3-methyladenine multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Alpha-Amanitin results in increased expression of ATG5 protein] more ... CTD PMID:18818525 more ... ATG5 Human 3-methyladenine increases expression EXP 6480464 3-methyladenine results in increased expression of ATG5 protein CTD PMID:32587277 ATG5 Human 3-methyladenine decreases expression EXP 6480464 3-methyladenine results in decreased expression of ATG5 protein CTD PMID:29781141 ATG5 Human 3-methyladenine multiple interactions ISO Atg5 (Mus musculus) 6480464 3-methyladenine affects the reaction [Dibutyl Phthalate results in increased expression of ATG5 protein] more ... CTD PMID:33462182 more ... ATG5 Human 3-methyladenine decreases expression ISO Atg5 (Rattus norvegicus) 6480464 3-methyladenine results in decreased expression of ATG5 mRNA and 3-methyladenine results in decreased expression of ATG5 protein CTD PMID:30611790 ATG5 Human 3-methyladenine multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 3-methyladenine inhibits the reaction [aristolochic acid I results in increased expression of ATG5 protein] more ... CTD PMID:23939141 more ... ATG5 Human 4'-epidoxorubicin decreases expression ISO Atg5 (Rattus norvegicus) 6480464 Epirubicin results in decreased expression of ATG5 protein CTD PMID:29505745 ATG5 Human 4'-epidoxorubicin multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 paeonol inhibits the reaction [Epirubicin results in decreased expression of ATG5 protein] and Sirolimus inhibits the reaction [Epirubicin results in decreased expression of ATG5 protein] CTD PMID:29505745 ATG5 Human 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ATG5 mRNA CTD PMID:28628672 ATG5 Human 4,4'-sulfonyldiphenol increases expression ISO Atg5 (Mus musculus) 6480464 bisphenol S results in increased expression of ATG5 mRNA CTD PMID:39298647 ATG5 Human 4,4'-sulfonyldiphenol decreases expression ISO Atg5 (Mus musculus) 6480464 bisphenol S results in decreased expression of ATG5 mRNA CTD PMID:29741722 ATG5 Human 4-hydroxynon-2-enal increases expression EXP 6480464 4-hydroxy-2-nonenal results in increased expression of ATG5 mRNA CTD PMID:35550146 ATG5 Human 4-nonylphenol increases expression ISO Atg5 (Rattus norvegicus) 6480464 4-nonylphenol results in increased expression of ATG5 mRNA CTD PMID:28041982 and PMID:30228064 ATG5 Human 4-phenylbutyric acid multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of ATG5 mRNA] and 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of ATG5 protein] CTD PMID:37654027 ATG5 Human 4-phenylbutyric acid multiple interactions ISO Atg5 (Mus musculus) 6480464 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG5 mRNA] and 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG5 protein] CTD PMID:34175825 ATG5 Human 5-aza-2'-deoxycytidine decreases expression ISO Atg5 (Rattus norvegicus) 6480464 Decitabine results in decreased expression of ATG5 protein CTD PMID:34536542 ATG5 Human acrolein increases expression EXP 6480464 Acrolein results in increased expression of ATG5 protein CTD PMID:30205151 ATG5 Human acrolein multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATG5 mRNA more ... CTD PMID:30205151 more ... ATG5 Human acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of ATG5 mRNA CTD PMID:32763439 ATG5 Human acrylamide increases expression ISO Atg5 (Mus musculus) 6480464 Acrylamide results in increased expression of ATG5 mRNA CTD PMID:34569336 ATG5 Human Aescin multiple interactions ISO Atg5 (Mus musculus) 6480464 ATG5 protein affects the reaction [Escin inhibits the reaction [Dietary Fats results in decreased expression of ACOX1 mRNA]] more ... CTD PMID:36905866 ATG5 Human Aescin increases expression EXP 6480464 Escin results in increased expression of ATG5 protein CTD PMID:36905866 ATG5 Human Aescin multiple interactions EXP 6480464 Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG5 protein] CTD PMID:36905866 ATG5 Human aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of ATG5 mRNA CTD PMID:21641981 ATG5 Human AICA ribonucleotide multiple interactions EXP 6480464 AICA ribonucleotide inhibits the reaction [Ethanol results in decreased expression of ATG5 protein] CTD PMID:24582693 ATG5 Human aldehydo-D-glucose decreases expression ISO Atg5 (Rattus norvegicus) 6480464 Glucose results in decreased expression of ATG5 protein CTD PMID:29128638 ATG5 Human aldehydo-D-glucose increases expression ISO Atg5 (Rattus norvegicus) 6480464 Glucose results in increased expression of ATG5 mRNA CTD PMID:38444079 ATG5 Human aldehydo-D-glucose multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 3-methyladenine inhibits the reaction [N-(1 more ... CTD PMID:29128638 and PMID:38444079 ATG5 Human all-trans-retinoic acid multiple interactions EXP 6480464 ATG5 protein affects the reaction [Tretinoin results in increased metabolism of and affects the localization of MAP1LC3B protein] more ... CTD PMID:28978663 and PMID:29743969 ATG5 Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of ATG5 mRNA and Tretinoin results in increased expression of ATG5 protein CTD PMID:29743969 ATG5 Human alpha,alpha-trehalose increases expression ISO Atg5 (Mus musculus) 6480464 Trehalose results in increased expression of ATG5 mRNA CTD PMID:23851366 ATG5 Human alpha-amanitin increases expression ISO Atg5 (Rattus norvegicus) 6480464 Alpha-Amanitin results in increased expression of ATG5 protein CTD PMID:37329965 ATG5 Human alpha-amanitin multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Alpha-Amanitin results in increased expression of ATG5 protein] CTD PMID:37329965 ATG5 Human alpha-D-galactose multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 candesartan inhibits the reaction [Galactose results in decreased expression of ATG5 mRNA] CTD PMID:34906534 ATG5 Human alpha-D-galactose decreases expression ISO Atg5 (Rattus norvegicus) 6480464 Galactose results in decreased expression of ATG5 mRNA CTD PMID:34906534 ATG5 Human alpha-pinene multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATG5 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ATG5 mRNA CTD PMID:32699268 ATG5 Human Alpinetin multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[alpinetin co-treated with TNF protein] results in increased expression of ATG5 mRNA] more ... CTD PMID:31676321 ATG5 Human Alpinetin multiple interactions ISO Atg5 (Mus musculus) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG5 mRNA]] more ... CTD PMID:31676321 ATG5 Human amiodarone affects response to substance EXP 6480464 ATG5 protein affects the susceptibility to Amiodarone CTD PMID:32651653 ATG5 Human antirheumatic drug increases expression EXP 6480464 Antirheumatic Agents results in increased expression of ATG5 mRNA CTD PMID:24449571 ATG5 Human aristolochic acid A multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 3-methyladenine inhibits the reaction [aristolochic acid I results in increased expression of ATG5 protein] and ATG5 affects the reaction [aristolochic acid I results in increased cleavage of PARP1 protein] CTD PMID:23939141 ATG5 Human aristolochic acid A decreases expression EXP 6480464 aristolochic acid I results in decreased expression of ATG5 mRNA CTD PMID:33212167 ATG5 Human aristolochic acid A increases response to substance ISO Atg5 (Rattus norvegicus) 6480464 ATG5 results in increased susceptibility to aristolochic acid I CTD PMID:23939141 ATG5 Human aristolochic acid A increases expression ISO Atg5 (Rattus norvegicus) 6480464 aristolochic acid I results in increased expression of ATG5 protein CTD PMID:23939141 ATG5 Human arsenite(3-) increases expression EXP 6480464 arsenite results in increased expression of ATG5 mRNA and arsenite results in increased expression of ATG5 protein CTD PMID:34929507 ATG5 Human arsenous acid increases expression ISO Atg5 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of ATG5 mRNA CTD PMID:30032600 more ... ATG5 Human arsenous acid decreases expression ISO Atg5 (Rattus norvegicus) 6480464 Arsenic Trioxide results in decreased expression of ATG5 protein CTD PMID:35195477 ATG5 Human arsenous acid multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 ferrostatin-1 inhibits the reaction [Arsenic Trioxide results in decreased expression of ATG5 protein] CTD PMID:35195477 ATG5 Human arsenous acid multiple interactions ISO Atg5 (Mus musculus) 6480464 3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA] and Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA] CTD PMID:33462182 ATG5 Human arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of ATG5 mRNA and Arsenic Trioxide results in increased expression of ATG5 protein CTD PMID:21594580 more ... ATG5 Human arsenous acid multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA] more ... CTD PMID:28978663 more ... ATG5 Human artesunate increases expression EXP 6480464 Artesunate results in increased expression of ATG5 mRNA CTD PMID:30551460 ATG5 Human atorvastatin calcium multiple interactions ISO Atg5 (Mus musculus) 6480464 ATG5 mutant form promotes the reaction [Atorvastatin results in increased cleavage of CASP3 protein] and ATG5 mutant form promotes the reaction [Atorvastatin results in increased cleavage of PARP1 protein] CTD PMID:20876807 ATG5 Human atorvastatin calcium increases response to substance ISO Atg5 (Mus musculus) 6480464 ATG5 results in increased susceptibility to Atorvastatin CTD PMID:20876807 ATG5 Human atrazine increases expression ISO Atg5 (Mus musculus) 6480464 Atrazine results in increased expression of ATG5 mRNA and Atrazine results in increased expression of ATG5 protein CTD PMID:33485040 ATG5 Human atrazine decreases expression ISO Atg5 (Mus musculus) 6480464 Atrazine results in decreased expression of ATG5 mRNA CTD PMID:30360616 ATG5 Human atrazine multiple interactions ISO Atg5 (Mus musculus) 6480464 Lycopene inhibits the reaction [Atrazine results in decreased expression of ATG5 mRNA] CTD PMID:30360616 ATG5 Human bafilomycin A1 multiple interactions EXP 6480464 ATG5 protein affects the reaction [bafilomycin A1 promotes the reaction [gossypol acetic acid results in increased expression of MAP1LC3B protein modified form]] CTD PMID:29938581 ATG5 Human bafilomycin A1 multiple interactions ISO Atg5 (Mus musculus) 6480464 [bafilomycin A1 co-treated with Swainsonine] results in increased expression of ATG5 mRNA and [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of ATG5 protein CTD PMID:36402259 ATG5 Human benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of ATG5 promoter CTD PMID:27901495 ATG5 Human benzo[a]pyrene increases expression ISO Atg5 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of ATG5 mRNA and Benzo(a)pyrene results in increased expression of ATG5 protein CTD PMID:39454710 ATG5 Human benzo[a]pyrene diol epoxide I decreases expression EXP 6480464 7 more ... CTD PMID:19150397 and PMID:20018196 ATG5 Human bis(2-ethylhexyl) phthalate increases expression ISO Atg5 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of ATG5 mRNA CTD PMID:34863575 ATG5 Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ATG5 mRNA CTD PMID:20678512 ATG5 Human bisphenol A increases expression ISO Atg5 (Mus musculus) 6480464 bisphenol A results in increased expression of ATG5 mRNA CTD PMID:34281243 ATG5 Human bisphenol A decreases expression ISO Atg5 (Mus musculus) 6480464 bisphenol A results in decreased expression of ATG5 mRNA CTD PMID:29741722 ATG5 Human bisphenol A multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ATG5 mRNA CTD PMID:28628672 ATG5 Human bisphenol A increases expression ISO Atg5 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of ATG5 mRNA CTD PMID:27539358 and PMID:30228064 ATG5 Human bisphenol A affects expression ISO Atg5 (Rattus norvegicus) 6480464 bisphenol A affects the expression of ATG5 mRNA CTD PMID:25181051 ATG5 Human bortezomib multiple interactions ISO Atg5 (Mus musculus) 6480464 ATG5 gene mutant form inhibits the reaction [Bortezomib results in increased cleavage of and results in increased activity of CASP3 protein] and ATG5 gene mutant form inhibits the reaction [HRAS protein promotes the reaction [Bortezomib results in increased cleavage of and results in increased activity of CASP3 protein]] CTD PMID:22842577 ATG5 Human buprofezin increases expression EXP 6480464 buprofezin results in increased expression of ATG5 mRNA CTD PMID:36287832 ATG5 Human butachlor increases expression ISO Atg5 (Mus musculus) 6480464 butachlor results in increased expression of ATG5 protein CTD PMID:34351278 ATG5 Human butachlor decreases expression ISO Atg5 (Mus musculus) 6480464 butachlor results in decreased expression of ATG5 mRNA CTD PMID:34351278 ATG5 Human butyric acid multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of ATG5 protein] CTD PMID:28600122 ATG5 Human butyric acid increases expression EXP 6480464 Butyric Acid results in increased expression of ATG5 protein CTD PMID:28600122 ATG5 Human cadmium acetate multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 [Sirolimus co-treated with cadmium acetate] results in increased expression of ATG5 mRNA and Chloroquine inhibits the reaction [cadmium acetate results in increased expression of ATG5 protein] CTD PMID:29870746 ATG5 Human cadmium acetate increases expression ISO Atg5 (Rattus norvegicus) 6480464 cadmium acetate results in increased expression of ATG5 protein CTD PMID:29870746 ATG5 Human cadmium atom multiple interactions ISO Atg5 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG5 protein more ... CTD PMID:29111403 more ... ATG5 Human cadmium atom affects response to substance ISO Atg5 (Mus musculus) 6480464 ATG5 protein affects the susceptibility to Cadmium CTD PMID:37506864 ATG5 Human cadmium atom multiple interactions EXP 6480464 ATG5 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SQSTM1 protein] and ATG5 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MTOR protein] CTD PMID:36336208 ATG5 Human cadmium atom multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 ATG5 protein affects the reaction [Cadmium results in decreased expression of SQSTM1 protein] more ... CTD PMID:27658547 ATG5 Human cadmium atom increases expression ISO Atg5 (Mus musculus) 6480464 Cadmium results in increased expression of ATG5 mRNA and Cadmium results in increased expression of ATG5 protein CTD PMID:27492225 and PMID:37148155 ATG5 Human cadmium dichloride multiple interactions ISO Atg5 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG5 protein CTD PMID:31862506 ATG5 Human cadmium dichloride multiple interactions EXP 6480464 ATG5 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SQSTM1 protein] and ATG5 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MTOR protein] CTD PMID:36336208 ATG5 Human cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of ATG5 protein CTD PMID:33127495 ATG5 Human calcitriol increases response to substance EXP 6480464 ATG5 results in increased susceptibility to Calcitriol CTD PMID:19748465 ATG5 Human calcitriol multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol results in increased activity of ATG5 mRNA] more ... CTD PMID:19748465 ATG5 Human calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of ATG5 mRNA CTD PMID:19748465 ATG5 Human camptothecin multiple interactions EXP 6480464 ATG5 mutant form inhibits the reaction [Camptothecin results in increased degradation of SQSTM1 protein] CTD PMID:22927544 ATG5 Human candesartan multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 candesartan inhibits the reaction [Galactose results in decreased expression of ATG5 mRNA] CTD PMID:34906534 ATG5 Human capsaicin multiple interactions EXP 6480464 ATG5 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of ATM protein] and ATG5 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of PRKDC protein] CTD PMID:22226932 ATG5 Human capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of ATG5 protein CTD PMID:22226932 ATG5 Human carbamazepine multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 [[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in decreased expression of ATG5 mRNA and [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of ATG5 mRNA CTD PMID:35786680 ATG5 Human carbon disulfide decreases expression ISO Atg5 (Mus musculus) 6480464 Carbon Disulfide results in decreased expression of ATG5 mRNA and Carbon Disulfide results in decreased expression of ATG5 protein CTD PMID:31369747 ATG5 Human carbon disulfide multiple interactions ISO Atg5 (Mus musculus) 6480464 N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in decreased expression of ATG5 mRNA] CTD PMID:31369747 ATG5 Human carbon nanotube increases expression ISO Atg5 (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of ATG5 protein CTD PMID:24929217 ATG5 Human carbon nanotube multiple interactions EXP 6480464 ATG5 protein affects the reaction [Nanotubes more ... CTD PMID:39033796 ATG5 Human carbon nanotube increases expression ISO Atg5 (Rattus norvegicus) 6480464 Nanotubes and Carbon results in increased expression of ATG5 mRNA CTD PMID:32951350 ATG5 Human carglumic acid multiple interactions ISO Atg5 (Mus musculus) 6480464 N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in decreased expression of ATG5 mRNA] CTD PMID:31369747 ATG5 Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to ATG5 gene] CTD PMID:28238834 ATG5 Human chloroquine multiple interactions EXP 6480464 Chloroquine inhibits the reaction [hydroxyethyl methacrylate results in increased expression of ATG5 protein] and Chloroquine promotes the reaction [Arsenic Trioxide results in increased expression of ATG5 protein] CTD PMID:28184909 and PMID:30338810 ATG5 Human chloroquine increases expression EXP 6480464 Chloroquine results in increased expression of ATG5 protein CTD PMID:30338810 ATG5 Human chloroquine multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 Chloroquine inhibits the reaction [cadmium acetate results in increased expression of ATG5 protein] CTD PMID:29870746 ATG5 Human chromium(6+) multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ATG5 protein CTD PMID:36849043 ATG5 Human cisplatin multiple interactions ISO Atg5 (Mus musculus) 6480464 Oleanolic Acid inhibits the reaction [Cisplatin results in increased expression of ATG5 protein] CTD PMID:31306688 ATG5 Human cisplatin multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 saponin Rb1 and Panax notoginsenoside promotes the reaction [Cisplatin results in increased expression of ATG5 protein] CTD PMID:25598344 ATG5 Human cisplatin increases expression ISO Atg5 (Rattus norvegicus) 6480464 Cisplatin results in increased expression of ATG5 protein CTD PMID:25598344 ATG5 Human cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of ATG5 protein CTD PMID:28408137 ATG5 Human cisplatin increases expression ISO Atg5 (Mus musculus) 6480464 Cisplatin results in increased expression of ATG5 protein CTD PMID:31306688 ATG5 Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of ATG5 protein CTD PMID:24817946 ATG5 Human cisplatin decreases response to substance EXP 6480464 ATG5 protein results in decreased susceptibility to Cisplatin CTD PMID:21351258 ATG5 Human cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with acetyl-11-ketoboswellic acid] results in decreased expression of ATG5 protein more ... CTD PMID:21743489 more ... ATG5 Human colistin increases expression ISO Atg5 (Mus musculus) 6480464 Colistin results in increased expression of ATG5 mRNA CTD PMID:35378205 ATG5 Human copper atom multiple interactions ISO Atg5 (Mus musculus) 6480464 [Copper Sulfate results in increased abundance of Copper] which results in increased expression of ATG5 mRNA and [Copper Sulfate results in increased abundance of Copper] which results in increased expression of ATG5 protein CTD PMID:31491480 ATG5 Human copper(0) multiple interactions ISO Atg5 (Mus musculus) 6480464 [Copper Sulfate results in increased abundance of Copper] which results in increased expression of ATG5 mRNA and [Copper Sulfate results in increased abundance of Copper] which results in increased expression of ATG5 protein CTD PMID:31491480 ATG5 Human copper(II) sulfate multiple interactions ISO Atg5 (Mus musculus) 6480464 [Copper Sulfate results in increased abundance of Copper] which results in increased expression of ATG5 mRNA and [Copper Sulfate results in increased abundance of Copper] which results in increased expression of ATG5 protein CTD PMID:31491480 ATG5 Human cordycepin increases expression EXP 6480464 cordycepin results in increased expression of ATG5 mRNA CTD PMID:36881089 ATG5 Human crocin-1 multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 crocin inhibits the reaction [Blood Glucose results in increased expression of ATG5 protein] more ... CTD PMID:33021114 ATG5 Human curcumin decreases expression ISO Atg5 (Mus musculus) 6480464 Curcumin results in decreased expression of ATG5 protein CTD PMID:36640941 ATG5 Human curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Tunicamycin results in increased expression of ATG5 protein] CTD PMID:36640941 ATG5 Human curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of ATG5 protein CTD PMID:36640941 ATG5 Human Curcumol multiple interactions ISO Atg5 (Mus musculus) 6480464 ATG5 protein inhibits the reaction [curcumol inhibits the reaction [Carbon Tetrachloride results in increased activity of GPT protein]] more ... CTD PMID:33549628 ATG5 Human Curcumol multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 [ATG5 protein co-treated with curcumol] inhibits the reaction [VEGFA protein results in increased expression of ANGPT2 protein] more ... CTD PMID:33549628 ATG5 Human cyclophosphamide multiple interactions ISO Atg5 (Mus musculus) 6480464 Fungal Polysaccharides inhibits the reaction [Cyclophosphamide results in decreased expression of ATG5 protein] and Levamisole inhibits the reaction [Cyclophosphamide results in decreased expression of ATG5 protein] CTD PMID:32151603 ATG5 Human cyclophosphamide decreases expression ISO Atg5 (Mus musculus) 6480464 Cyclophosphamide results in decreased expression of ATG5 protein CTD PMID:32151603 ATG5 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of ATG5 mRNA CTD PMID:25562108 ATG5 Human cypermethrin increases expression EXP 6480464 cypermethrin results in increased expression of ATG5 mRNA CTD PMID:27704156 ATG5 Human D-glucose multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 3-methyladenine inhibits the reaction [N-(1 more ... CTD PMID:29128638 and PMID:38444079 ATG5 Human D-glucose increases expression ISO Atg5 (Rattus norvegicus) 6480464 Glucose results in increased expression of ATG5 mRNA CTD PMID:38444079 ATG5 Human D-glucose decreases expression ISO Atg5 (Rattus norvegicus) 6480464 Glucose results in decreased expression of ATG5 protein CTD PMID:29128638 ATG5 Human dapagliflozin multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 dapagliflozin inhibits the reaction [Doxorubicin results in increased expression of ATG5 mRNA] CTD PMID:38997059 ATG5 Human deoxynivalenol multiple interactions ISO Atg5 (Mus musculus) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 mRNA]] more ... CTD PMID:35381244 ATG5 Human deoxynivalenol increases expression ISO Atg5 (Mus musculus) 6480464 deoxynivalenol results in increased expression of ATG5 mRNA and deoxynivalenol results in increased expression of ATG5 protein CTD PMID:35381244 ATG5 Human dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ATG5 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ATG5 mRNA CTD PMID:28628672 ATG5 Human dextran sulfate increases expression ISO Atg5 (Mus musculus) 6480464 Dextran Sulfate results in increased expression of ATG5 mRNA CTD PMID:31676321 ATG5 Human dextran sulfate multiple interactions ISO Atg5 (Mus musculus) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG5 mRNA]] more ... CTD PMID:27611972 more ... ATG5 Human diarsenic trioxide multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA] more ... CTD PMID:28978663 more ... ATG5 Human diarsenic trioxide multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 ferrostatin-1 inhibits the reaction [Arsenic Trioxide results in decreased expression of ATG5 protein] CTD PMID:35195477 ATG5 Human diarsenic trioxide decreases expression ISO Atg5 (Rattus norvegicus) 6480464 Arsenic Trioxide results in decreased expression of ATG5 protein CTD PMID:35195477 ATG5 Human diarsenic trioxide multiple interactions ISO Atg5 (Mus musculus) 6480464 3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA] and Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA] CTD PMID:33462182 ATG5 Human diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of ATG5 mRNA and Arsenic Trioxide results in increased expression of ATG5 protein CTD PMID:21594580 more ... ATG5 Human diarsenic trioxide increases expression ISO Atg5 (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of ATG5 mRNA CTD PMID:30032600 more ... ATG5 Human dibutyl phthalate increases expression ISO Atg5 (Rattus norvegicus) 6480464 Dibutyl Phthalate results in increased expression of ATG5 mRNA CTD PMID:30053495 ATG5 Human dibutyl phthalate increases expression ISO Atg5 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of ATG5 protein CTD PMID:37277016 ATG5 Human dibutyl phthalate multiple interactions ISO Atg5 (Mus musculus) 6480464 3-methyladenine affects the reaction [Dibutyl Phthalate results in increased expression of ATG5 protein] CTD PMID:37277016 ATG5 Human dicrotophos decreases expression EXP 6480464 dicrotophos results in decreased expression of ATG5 mRNA CTD PMID:28302478 ATG5 Human dieldrin affects methylation ISO Atg5 (Mus musculus) 6480464 Dieldrin affects the methylation of ATG5 gene CTD PMID:38995845 ATG5 Human diisononyl phthalate increases expression EXP 6480464 diisononyl phthalate results in increased expression of ATG5 protein CTD PMID:37976928 ATG5 Human diisononyl phthalate multiple interactions EXP 6480464 ATF4 protein promotes the reaction [diisononyl phthalate results in increased expression of ATG5 protein] and DDIT4 protein promotes the reaction [diisononyl phthalate results in increased expression of ATG5 protein] CTD PMID:37976928 ATG5 Human dioxygen multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 sanggenone C inhibits the reaction [Oxygen deficiency results in decreased expression of ATG5 mRNA] CTD PMID:28983604 ATG5 Human dioxygen decreases expression ISO Atg5 (Rattus norvegicus) 6480464 Oxygen deficiency results in decreased expression of ATG5 mRNA CTD PMID:28983604 ATG5 Human diphenhydramine affects response to substance ISO Atg5 (Mus musculus) 6480464 ATG5 protein affects the susceptibility to Diphenhydramine CTD PMID:22310178 ATG5 Human diquat increases expression EXP 6480464 Diquat results in increased expression of ATG5 protein CTD PMID:38128689 ATG5 Human disodium selenite increases expression EXP 6480464 Sodium Selenite results in increased expression of ATG5 protein CTD PMID:25204997 ATG5 Human Doramectin increases expression ISO Atg5 (Rattus norvegicus) 6480464 doramectin results in increased expression of ATG5 protein CTD PMID:35137919 ATG5 Human Doramectin increases expression EXP 6480464 doramectin results in increased expression of ATG5 protein CTD PMID:35137919 ATG5 Human doxorubicin multiple interactions EXP 6480464 PQQ Cofactor inhibits the reaction [Doxorubicin results in increased expression of ATG5 protein] CTD PMID:31226464 ATG5 Human doxorubicin increases expression ISO Atg5 (Rattus norvegicus) 6480464 Doxorubicin results in increased expression of ATG5 mRNA and Doxorubicin results in increased expression of ATG5 protein CTD PMID:36639017 and PMID:38997059 ATG5 Human doxorubicin multiple interactions ISO Atg5 (Mus musculus) 6480464 OTUD7B protein inhibits the reaction [Doxorubicin results in increased expression of ATG5 protein] and Sirolimus inhibits the reaction [OTUD7B protein inhibits the reaction [Doxorubicin results in increased expression of ATG5 protein]] CTD PMID:36639017 ATG5 Human doxorubicin increases expression ISO Atg5 (Mus musculus) 6480464 Doxorubicin results in increased expression of ATG5 protein CTD PMID:36639017 ATG5 Human doxorubicin multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 [4-(((4-carboxybutyl) (2- (5-fluoro-2-((4'-(trifluoromethyl) biphenyl-4-yl)methoxy)phenyl)ethyl) amino)methyl)benzoic acid co-treated with Doxorubicin] results in increased expression of ATG5 protein more ... CTD PMID:32652078 more ... ATG5 Human doxorubicin decreases expression ISO Atg5 (Rattus norvegicus) 6480464 Doxorubicin results in decreased expression of ATG5 mRNA CTD PMID:34933056 ATG5 Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of ATG5 mRNA CTD PMID:29803840 ATG5 Human doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of ATG5 protein CTD PMID:31226464 ATG5 Human ellagic acid increases expression EXP 6480464 Ellagic Acid results in increased expression of ATG5 mRNA CTD PMID:12002526 ATG5 Human embelin multiple interactions EXP 6480464 embelin results in increased cleavage of [ATG12 protein binds to ATG5 protein] CTD PMID:28722333 ATG5 Human erastin increases expression ISO Atg5 (Rattus norvegicus) 6480464 erastin results in increased expression of ATG5 protein CTD PMID:32937103 ATG5 Human erlotinib hydrochloride decreases response to substance EXP 6480464 ATG5 protein results in decreased susceptibility to Erlotinib Hydrochloride CTD PMID:23917044 ATG5 Human erlotinib hydrochloride increases expression EXP 6480464 Erlotinib Hydrochloride results in increased expression of ATG5 protein CTD PMID:21655094 ATG5 Human ethanol multiple interactions ISO Atg5 (Mus musculus) 6480464 NR1H4 gene mutant form inhibits the reaction [Ethanol results in increased expression of ATG5 mRNA] more ... CTD PMID:24095927 more ... ATG5 Human ethanol decreases expression ISO Atg5 (Mus musculus) 6480464 Ethanol results in decreased expression of ATG5 protein CTD PMID:34405320 ATG5 Human ethanol decreases expression ISO Atg5 (Rattus norvegicus) 6480464 Ethanol results in decreased expression of ATG5 protein CTD PMID:24582693 ATG5 Human ethanol multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 ADIPOQ protein inhibits the reaction [Ethanol results in decreased expression of ATG5 protein] CTD PMID:24582693 ATG5 Human ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of ATG5 mRNA and Ethanol results in decreased expression of ATG5 protein CTD PMID:24582693 and PMID:34405320 ATG5 Human ethanol multiple interactions EXP 6480464 ADIPOQ protein inhibits the reaction [Ethanol results in decreased expression of ATG5 mRNA] more ... CTD PMID:24582693 and PMID:34405320 ATG5 Human ethanol decreases response to substance EXP 6480464 ATG5 protein results in decreased susceptibility to Ethanol CTD PMID:24582693 ATG5 Human ethanol increases expression ISO Atg5 (Mus musculus) 6480464 Ethanol results in increased expression of ATG5 mRNA and Ethanol results in increased expression of ATG5 protein CTD PMID:24095927 more ... ATG5 Human ethanol increases expression EXP 6480464 Ethanol results in increased expression of ATG5 mRNA CTD PMID:24095927 ATG5 Human ferric oxide increases expression ISO Atg5 (Mus musculus) 6480464 ferric oxide analog results in increased expression of ATG5 protein CTD PMID:24068039 ATG5 Human ferrostatin-1 multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 ferrostatin-1 inhibits the reaction [Arsenic Trioxide results in decreased expression of ATG5 protein] CTD PMID:35195477 ATG5 Human fingolimod hydrochloride increases expression EXP 6480464 Fingolimod Hydrochloride results in increased expression of ATG5 protein CTD PMID:25939952 ATG5 Human flavokawain B affects response to substance EXP 6480464 ATG5 protein affects the susceptibility to flavokawain B CTD PMID:30025493 ATG5 Human flavokawain B multiple interactions EXP 6480464 [ATG5 protein affects the susceptibility to flavokawain B] which affects the cleavage of CASP3 protein more ... CTD PMID:30025493 ATG5 Human flutamide increases expression ISO Atg5 (Rattus norvegicus) 6480464 Flutamide results in increased expression of ATG5 mRNA CTD PMID:24136188 ATG5 Human folic acid multiple interactions ISO Atg5 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATG5 mRNA CTD PMID:22206623 ATG5 Human Fusaric acid increases expression EXP 6480464 Fusaric Acid results in increased expression of ATG5 mRNA CTD PMID:30582969 ATG5 Human galactose decreases expression ISO Atg5 (Rattus norvegicus) 6480464 Galactose results in decreased expression of ATG5 mRNA CTD PMID:34906534 ATG5 Human galactose multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 candesartan inhibits the reaction [Galactose results in decreased expression of ATG5 mRNA] CTD PMID:34906534 ATG5 Human gefitinib increases expression EXP 6480464 gefitinib results in increased expression of ATG5 protein CTD PMID:21655094 ATG5 Human genistein increases expression EXP 6480464 Genistein results in increased expression of ATG5 mRNA CTD PMID:15256057 ATG5 Human geraniol multiple interactions EXP 6480464 geraniol inhibits the reaction [Rotenone results in decreased expression of ATG5 protein] CTD PMID:30141137 ATG5 Human glucose multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 3-methyladenine inhibits the reaction [N-(1 more ... CTD PMID:29128638 and PMID:38444079 ATG5 Human glucose increases expression ISO Atg5 (Rattus norvegicus) 6480464 Glucose results in increased expression of ATG5 mRNA CTD PMID:38444079 ATG5 Human glucose decreases expression ISO Atg5 (Rattus norvegicus) 6480464 Glucose results in decreased expression of ATG5 protein CTD PMID:29128638 ATG5 Human glutathione affects abundance ISO Atg5 (Mus musculus) 6480464 ATG5 protein affects the abundance of Glutathione CTD PMID:22491424 ATG5 Human glutathione multiple interactions ISO Atg5 (Mus musculus) 6480464 [ATG5 gene mutant form results in increased activity of NFE2L2 protein] affects the reaction [Acetaminophen affects the abundance of Glutathione] more ... CTD PMID:22491424 ATG5 Human glycochenodeoxycholic acid decreases expression EXP 6480464 Glycochenodeoxycholic Acid results in decreased expression of ATG5 mRNA and Glycochenodeoxycholic Acid results in decreased expression of ATG5 protein CTD PMID:32439580 ATG5 Human glycochenodeoxycholic acid multiple interactions EXP 6480464 TFE3 protein inhibits the reaction [Glycochenodeoxycholic Acid results in decreased expression of ATG5 mRNA] CTD PMID:32439580 ATG5 Human glyphosate increases expression EXP 6480464 Glyphosate results in increased expression of ATG5 mRNA CTD PMID:31874349 ATG5 Human gossypetin multiple interactions EXP 6480464 gossypetin promotes the reaction [malondialdehyde-low density lipoprotein and human promotes the reaction [ATG5 protein binds to ATG12 protein]] CTD PMID:25622137 ATG5 Human hesperetin multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 hesperetin inhibits the reaction [Doxorubicin results in decreased expression of ATG5 mRNA] CTD PMID:34933056 ATG5 Human hexadecanoic acid multiple interactions EXP 6480464 [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG5 protein more ... CTD PMID:25943029 and PMID:36905866 ATG5 Human hexadecanoic acid multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 ATG5 protein promotes the reaction [C1QTNF9 protein inhibits the reaction [Palmitic Acid results in increased expression of CASP3 protein modified form]] CTD PMID:32278738 ATG5 Human HU-308 multiple interactions ISO Atg5 (Mus musculus) 6480464 ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]] and ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]] CTD PMID:27611972 ATG5 Human hyaluronic acid increases cleavage ISO Atg5 (Rattus norvegicus) 6480464 Hyaluronic Acid results in increased cleavage of ATG5 protein CTD PMID:27082295 ATG5 Human hyaluronic acid multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 roxadustat promotes the reaction [Hyaluronic Acid results in increased cleavage of ATG5 protein] CTD PMID:27082295 ATG5 Human hydroquinone multiple interactions EXP 6480464 PARP1 protein promotes the reaction [hydroquinone results in increased expression of ATG5 mRNA] and SIRT1 protein inhibits the reaction [hydroquinone results in increased expression of ATG5 mRNA] CTD PMID:28263894 ATG5 Human hydroquinone increases expression EXP 6480464 hydroquinone results in increased expression of ATG5 mRNA CTD PMID:28263894 ATG5 Human indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ATG5 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ATG5 mRNA CTD PMID:28628672 ATG5 Human ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of ATG5 protein CTD PMID:32959892 ATG5 Human JTE-013 multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of ATG5 protein] CTD PMID:37169277 ATG5 Human kainic acid multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of ATG5 protein] CTD PMID:32057834 ATG5 Human kainic acid increases expression ISO Atg5 (Rattus norvegicus) 6480464 Kainic Acid results in increased expression of ATG5 protein CTD PMID:32057834 ATG5 Human L-leucine multiple interactions ISO Atg5 (Mus musculus) 6480464 Leucine inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG5 mRNA]] CTD PMID:31676321 ATG5 Human lead diacetate multiple interactions ISO Atg5 (Mus musculus) 6480464 [lead acetate results in increased abundance of Lead] which results in increased expression of ATG5 mRNA CTD PMID:33445541 ATG5 Human lead diacetate multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 [lead acetate results in increased abundance of Lead] which results in increased expression of ATG5 mRNA and [lead acetate results in increased abundance of Lead] which results in increased expression of ATG5 protein CTD PMID:36652739 ATG5 Human lead(0) multiple interactions ISO Atg5 (Mus musculus) 6480464 [lead acetate results in increased abundance of Lead] which results in increased expression of ATG5 mRNA CTD PMID:33445541 ATG5 Human lead(0) multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 [lead acetate results in increased abundance of Lead] which results in increased expression of ATG5 mRNA and [lead acetate results in increased abundance of Lead] which results in increased expression of ATG5 protein CTD PMID:36652739 ATG5 Human levamisole multiple interactions ISO Atg5 (Mus musculus) 6480464 Levamisole inhibits the reaction [Cyclophosphamide results in decreased expression of ATG5 protein] CTD PMID:32151603 ATG5 Human lipopolysaccharide increases cleavage ISO Atg5 (Rattus norvegicus) 6480464 Lipopolysaccharides results in increased cleavage of ATG5 protein CTD PMID:24973090 ATG5 Human lipopolysaccharide increases expression ISO Atg5 (Rattus norvegicus) 6480464 Lipopolysaccharides results in increased expression of ATG5 mRNA and Lipopolysaccharides results in increased expression of ATG5 protein CTD PMID:37654027 ATG5 Human lipopolysaccharide affects response to substance ISO Atg5 (Mus musculus) 6480464 ATG5 protein affects the susceptibility to Lipopolysaccharides CTD PMID:30301768 ATG5 Human lipopolysaccharide multiple interactions ISO Atg5 (Mus musculus) 6480464 ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]] more ... CTD PMID:27611972 and PMID:30301768 ATG5 Human lipopolysaccharide multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 3-methyladenine promotes the reaction [Lipopolysaccharides results in increased expression of ATG5 protein] more ... CTD PMID:24973090 and PMID:37654027 ATG5 Human luteolin multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 Luteolin inhibits the reaction [Methamphetamine results in increased expression of ATG5 protein] CTD PMID:32035215 ATG5 Human luteolin increases expression EXP 6480464 Luteolin results in increased expression of ATG5 protein CTD PMID:32268164 ATG5 Human LY294002 multiple interactions ISO Atg5 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG5 mRNA]] and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG5 mRNA] CTD PMID:35568058 ATG5 Human lycopene multiple interactions ISO Atg5 (Mus musculus) 6480464 Lycopene inhibits the reaction [Atrazine results in decreased expression of ATG5 mRNA] CTD PMID:30360616 ATG5 Human lycopene multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 [Glucose co-treated with Lycopene] results in increased expression of ATG5 mRNA CTD PMID:38444079 ATG5 Human melatonin multiple interactions ISO Atg5 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG5 mRNA]] and Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG5 mRNA] CTD PMID:35568058 ATG5 Human menadione affects response to substance ISO Atg5 (Rattus norvegicus) 6480464 ATG5 mRNA affects the susceptibility to Vitamin K 3 CTD PMID:20578144 ATG5 Human menadione affects response to substance ISO Atg5 (Mus musculus) 6480464 ATG5 protein affects the susceptibility to Vitamin K 3 CTD PMID:18073215 and PMID:18319638 ATG5 Human metformin multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 Metformin inhibits the reaction [Blood Glucose results in increased expression of ATG5 protein] CTD PMID:33021114 ATG5 Human methamphetamine multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 Luteolin inhibits the reaction [Methamphetamine results in increased expression of ATG5 protein] CTD PMID:32035215 ATG5 Human methamphetamine increases expression ISO Atg5 (Mus musculus) 6480464 Methamphetamine results in increased expression of ATG5 protein CTD PMID:33359793 ATG5 Human methamphetamine increases expression ISO Atg5 (Rattus norvegicus) 6480464 Methamphetamine results in increased expression of ATG5 mRNA and Methamphetamine results in increased expression of ATG5 protein CTD PMID:32035215 more ... ATG5 Human methoxychlor affects methylation ISO Atg5 (Rattus norvegicus) 6480464 Methoxychlor affects the methylation of ATG5 gene CTD PMID:35440735 ATG5 Human methylisothiazolinone increases expression EXP 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of ATG5 protein CTD PMID:29110394 ATG5 Human methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of ATG5 mRNA CTD PMID:23179753 and PMID:27188386 ATG5 Human methylmercury chloride multiple interactions ISO Atg5 (Mus musculus) 6480464 ATG5 promotes the reaction [methylmercuric chloride results in increased cleavage of CASP3 protein] more ... CTD PMID:27667695 ATG5 Human methylmercury chloride affects response to substance ISO Atg5 (Mus musculus) 6480464 ATG5 affects the susceptibility to methylmercuric chloride CTD PMID:27667695 ATG5 Human methylphenidate increases expression ISO Atg5 (Rattus norvegicus) 6480464 Methylphenidate results in increased expression of ATG5 mRNA CTD PMID:32746681 ATG5 Human microcystin-LR multiple interactions ISO Atg5 (Mus musculus) 6480464 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG5 mRNA] and 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG5 protein] CTD PMID:34175825 ATG5 Human microcystin-LR increases expression ISO Atg5 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of ATG5 mRNA and cyanoginosin LR results in increased expression of ATG5 protein CTD PMID:34175825 ATG5 Human mitoxantrone decreases expression EXP 6480464 Mitoxantrone results in decreased expression of ATG5 protein CTD PMID:36216988 ATG5 Human MJN110 multiple interactions ISO Atg5 (Mus musculus) 6480464 ATG5 protein affects the reaction [MJN110 affects the reaction [Lipopolysaccharides affects the secretion of CCL2 protein]] more ... CTD PMID:30301768 ATG5 Human N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 3-methyladenine inhibits the reaction [N-(1 more ... CTD PMID:29128638 ATG5 Human N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Acrolein results in increased expression of ATG5 protein] more ... CTD PMID:20543569 more ... ATG5 Human N-acetyl-L-cysteine multiple interactions ISO Atg5 (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA] and Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased expression of ATG5 mRNA] CTD PMID:24614525 and PMID:33462182 ATG5 Human N-methyl-4-phenylpyridinium affects response to substance EXP 6480464 ATG5 protein affects the susceptibility to 1-Methyl-4-phenylpyridinium CTD PMID:23997112 ATG5 Human N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 ATG5 protein promotes the reaction [1-Methyl-4-phenylpyridinium results in increased cleavage of and results in increased activity of CASP3 protein] CTD PMID:23997112 ATG5 Human NADP zwitterion multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of ATG5 protein] CTD PMID:32057834 ATG5 Human NADP(+) multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of ATG5 protein] CTD PMID:32057834 ATG5 Human nickel atom multiple interactions EXP 6480464 [Nickel co-treated with austenitic steel analog] results in increased expression of ATG5 mRNA CTD PMID:23638002 ATG5 Human nickel atom multiple interactions ISO Atg5 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG5 mRNA]] more ... CTD PMID:35568058 ATG5 Human nickel atom increases expression EXP 6480464 Nickel results in increased expression of ATG5 mRNA CTD PMID:25583101 ATG5 Human nickel dichloride multiple interactions ISO Atg5 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG5 mRNA]] more ... CTD PMID:35568058 ATG5 Human Nonidet P-40 decreases expression EXP 6480464 Nonidet P-40 results in decreased expression of ATG5 mRNA CTD PMID:26552463 ATG5 Human obeticholic acid multiple interactions ISO Atg5 (Mus musculus) 6480464 obeticholic acid inhibits the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in decreased expression of ATG5 mRNA] CTD PMID:35439472 ATG5 Human oleanolic acid increases expression EXP 6480464 Oleanolic Acid analog results in increased expression of ATG5 protein and Oleanolic Acid results in increased expression of ATG5 protein CTD PMID:26612655 and PMID:35690101 ATG5 Human oleanolic acid multiple interactions ISO Atg5 (Mus musculus) 6480464 Oleanolic Acid inhibits the reaction [Cisplatin results in increased expression of ATG5 protein] CTD PMID:31306688 ATG5 Human oleic acid multiple interactions EXP 6480464 [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG5 protein and Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG5 protein] CTD PMID:36905866 ATG5 Human oligopeptide increases expression EXP 6480464 Oligopeptides analog results in increased expression of ATG5 protein CTD PMID:24875536 ATG5 Human ozone multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATG5 mRNA more ... CTD PMID:32699268 and PMID:32845096 ATG5 Human p-menthan-3-ol increases expression EXP 6480464 Menthol results in increased expression of ATG5 mRNA CTD PMID:26760959 ATG5 Human Paeonol multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 paeonol inhibits the reaction [Epirubicin results in decreased expression of ATG5 protein] CTD PMID:29505745 ATG5 Human paracetamol affects expression ISO Atg5 (Mus musculus) 6480464 Acetaminophen affects the expression of ATG5 mRNA CTD PMID:17562736 ATG5 Human paracetamol multiple interactions ISO Atg5 (Mus musculus) 6480464 [ATG5 gene mutant form results in increased activity of NFE2L2 protein] affects the reaction [Acetaminophen affects the abundance of Glutathione] more ... CTD PMID:22491424 ATG5 Human paracetamol affects response to substance ISO Atg5 (Mus musculus) 6480464 ATG5 protein affects the susceptibility to Acetaminophen CTD PMID:22491424 ATG5 Human paraquat affects response to substance EXP 6480464 ATG5 protein affects the susceptibility to Paraquat CTD PMID:22982048 and PMID:23997112 ATG5 Human paraquat affects response to substance ISO Atg5 (Rattus norvegicus) 6480464 ATG5 protein affects the susceptibility to Paraquat CTD PMID:27324791 ATG5 Human paraquat affects response to substance ISO Atg5 (Mus musculus) 6480464 ATG5 protein affects the susceptibility to Paraquat CTD PMID:22982048 ATG5 Human paraquat increases expression EXP 6480464 Paraquat results in increased expression of ATG5 mRNA CTD PMID:27220436 ATG5 Human paraquat increases expression ISO Atg5 (Mus musculus) 6480464 Paraquat results in increased expression of ATG5 mRNA and Paraquat results in increased expression of ATG5 protein CTD PMID:22982048 more ... ATG5 Human paraquat multiple interactions ISO Atg5 (Mus musculus) 6480464 [ATG5 protein affects the susceptibility to Paraquat] which affects the abundance of Lipofuscin more ... CTD PMID:22982048 and PMID:27246695 ATG5 Human paraquat multiple interactions EXP 6480464 [ATG5 protein affects the susceptibility to Paraquat] which affects the abundance of Lipofuscin more ... CTD PMID:22982048 more ... ATG5 Human patulin multiple interactions EXP 6480464 ATG5 protein affects the reaction [Patulin results in increased expression of and results in increased cleavage of GSDMD protein] and ATG5 protein affects the reaction [Patulin results in increased expression of IL1B protein] CTD PMID:33217525 ATG5 Human perfluorooctane-1-sulfonic acid increases expression ISO Atg5 (Rattus norvegicus) 6480464 perfluorooctane sulfonic acid results in increased expression of ATG5 mRNA CTD PMID:27825932 ATG5 Human perfluorooctanoic acid multiple interactions EXP 6480464 ATG5 protein promotes the reaction [perfluorooctanoic acid results in increased expression of MAP1LC3B protein modified form] CTD PMID:26879310 ATG5 Human perfluorooctanoic acid increases expression ISO Atg5 (Mus musculus) 6480464 perfluorooctanoic acid results in increased expression of ATG5 mRNA CTD PMID:26879310 ATG5 Human phenobarbital multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 Phenobarbital inhibits the reaction [Dietary Fats results in increased expression of ATG5 mRNA] CTD PMID:36657701 ATG5 Human pirinixic acid increases expression ISO Atg5 (Mus musculus) 6480464 pirinixic acid results in increased expression of ATG5 mRNA CTD PMID:23811191 ATG5 Human potassium chromate decreases expression EXP 6480464 potassium chromate(VI) results in decreased expression of ATG5 mRNA CTD PMID:22079256 ATG5 Human potassium chromate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATG5 mRNA CTD PMID:22079256 ATG5 Human potassium dichromate multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ATG5 protein CTD PMID:36849043 ATG5 Human promethazine decreases expression EXP 6480464 Promethazine results in decreased expression of ATG5 protein CTD PMID:31682805 ATG5 Human propiconazole decreases expression ISO Atg5 (Mus musculus) 6480464 propiconazole results in decreased expression of ATG5 mRNA CTD PMID:21278054 ATG5 Human psoralen increases expression ISO Atg5 (Mus musculus) 6480464 Ficusin results in increased expression of ATG5 protein CTD PMID:39299507 ATG5 Human pterostilbene multiple interactions ISO Atg5 (Mus musculus) 6480464 pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein] and SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein]] CTD PMID:34405320 ATG5 Human pterostilbene multiple interactions EXP 6480464 pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein] and SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein]] CTD PMID:34405320 ATG5 Human pyrroloquinoline quinone multiple interactions EXP 6480464 PQQ Cofactor inhibits the reaction [Doxorubicin results in increased expression of ATG5 protein] CTD PMID:31226464 ATG5 Human quercetin multiple interactions EXP 6480464 Quercetin results in increased expression of [ATG12 protein binds to ATG5 protein] CTD PMID:25293876 ATG5 Human quercetin multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 crocin promotes the reaction [Quercetin inhibits the reaction [Blood Glucose results in increased expression of ATG5 protein]] more ... CTD PMID:33021114 and PMID:34751495 ATG5 Human rac-lactic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of ATG5 mRNA CTD PMID:30851411 ATG5 Human raloxifene multiple interactions EXP 6480464 Raloxifene Hydrochloride promotes the reaction [ATG12 protein binds to ATG5 protein] CTD PMID:25537862 ATG5 Human reactive oxygen species decreases abundance EXP 6480464 ATG5 protein results in decreased abundance of Reactive Oxygen Species CTD PMID:31926197 ATG5 Human resveratrol affects response to substance EXP 6480464 ATG5 protein affects the susceptibility to resveratrol CTD PMID:23680031 ATG5 Human resveratrol increases expression ISO Atg5 (Mus musculus) 6480464 resveratrol results in increased expression of ATG5 mRNA CTD PMID:24095927 ATG5 Human resveratrol multiple interactions ISO Atg5 (Mus musculus) 6480464 resveratrol promotes the reaction [Ethanol results in increased expression of ATG5 mRNA] CTD PMID:24095927 ATG5 Human resveratrol multiple interactions EXP 6480464 ATG5 protein affects the reaction [[TNF protein co-treated with Resveratrol] results in increased expression of MAP1LC3B protein alternative form] more ... CTD PMID:23680031 more ... ATG5 Human resveratrol increases expression EXP 6480464 resveratrol results in increased expression of ATG5 mRNA CTD PMID:12002526 more ... ATG5 Human rotenone multiple interactions EXP 6480464 ATG5 protein affects the reaction [Sirolimus inhibits the reaction [Rotenone results in increased cleavage of PARP1 protein]] more ... CTD PMID:19682553 more ... ATG5 Human rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of ATG5 protein CTD PMID:30141137 and PMID:31926197 ATG5 Human rotenone increases expression ISO Atg5 (Rattus norvegicus) 6480464 Rotenone results in increased expression of ATG5 protein CTD PMID:25725130 ATG5 Human rotenone multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 [Particulate Matter co-treated with Rotenone] results in decreased expression of ATG5 protein more ... CTD PMID:25725130 and PMID:33823232 ATG5 Human rotenone affects response to substance EXP 6480464 ATG5 protein affects the susceptibility to Rotenone CTD PMID:18032788 ATG5 Human roxadustat multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 roxadustat promotes the reaction [Hyaluronic Acid results in increased cleavage of ATG5 protein] CTD PMID:27082295 ATG5 Human ruthenium red multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 Ruthenium Red inhibits the reaction [Cadmium Compounds results in increased expression of ATG5 protein] CTD PMID:34308505 ATG5 Human Sanggenon C multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 sanggenone C inhibits the reaction [Oxygen deficiency results in decreased expression of ATG5 mRNA] CTD PMID:28983604 ATG5 Human SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [Calcitriol results in increased activity of ATG5 mRNA] CTD PMID:19748465 ATG5 Human sevoflurane increases expression EXP 6480464 Sevoflurane results in increased expression of ATG5 protein CTD PMID:35472370 ATG5 Human silicon dioxide increases expression ISO Atg5 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of ATG5 mRNA and Silicon Dioxide results in increased expression of ATG5 protein CTD PMID:33232774 ATG5 Human silicon dioxide multiple interactions ISO Atg5 (Mus musculus) 6480464 GAS6 gene mutant form inhibits the reaction [Silicon Dioxide results in increased expression of ATG5 mRNA] more ... CTD PMID:33232774 ATG5 Human sirolimus multiple interactions EXP 6480464 [Sirolimus co-treated with TNF protein] results in increased expression of ATG5 mRNA more ... CTD PMID:19682553 more ... ATG5 Human sirolimus multiple interactions ISO Atg5 (Mus musculus) 6480464 Sirolimus inhibits the reaction [OTUD7B protein inhibits the reaction [Doxorubicin results in increased expression of ATG5 protein]] CTD PMID:36639017 ATG5 Human sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of ATG5 protein CTD PMID:29781141 and PMID:30338810 ATG5 Human sirolimus increases expression ISO Atg5 (Rattus norvegicus) 6480464 Sirolimus results in increased expression of ATG5 mRNA and Sirolimus results in increased expression of ATG5 protein CTD PMID:30611790 ATG5 Human sirolimus multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 [Sirolimus co-treated with cadmium acetate] results in increased expression of ATG5 mRNA more ... CTD PMID:29128638 more ... ATG5 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of ATG5 protein CTD PMID:28888487 ATG5 Human sodium arsenite increases expression ISO Atg5 (Mus musculus) 6480464 sodium arsenite results in increased expression of ATG5 mRNA and sodium arsenite results in increased expression of ATG5 protein CTD PMID:38387523 ATG5 Human sodium arsenite multiple interactions ISO Atg5 (Mus musculus) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 mRNA]] more ... CTD PMID:30097599 and PMID:35381244 ATG5 Human sodium arsenite multiple interactions EXP 6480464 ATG5 protein affects the reaction [sodium arsenite results in increased activity of PARP1 protein] and ATG5 protein affects the reaction [sodium arsenite results in increased expression of BECN1 protein] CTD PMID:28888487 and PMID:36958258 ATG5 Human sodium fluoride increases expression ISO Atg5 (Mus musculus) 6480464 Sodium Fluoride results in increased expression of ATG5 mRNA and Sodium Fluoride results in increased expression of ATG5 protein CTD PMID:24296261 ATG5 Human sodium fluoride increases expression ISO Atg5 (Rattus norvegicus) 6480464 Sodium Fluoride results in increased expression of ATG5 mRNA and Sodium Fluoride results in increased expression of ATG5 protein CTD PMID:24296261 ATG5 Human Soman increases expression ISO Atg5 (Rattus norvegicus) 6480464 Soman results in increased expression of ATG5 protein CTD PMID:31102696 ATG5 Human sorafenib multiple interactions EXP 6480464 [sorafenib co-treated with vorinostat] promotes the reaction [FAS protein binds to CASP8 protein binds to ATG5 protein binds to HSPA5 protein] more ... CTD PMID:18787411 ATG5 Human sorafenib increases expression EXP 6480464 sorafenib results in increased expression of ATG5 protein CTD PMID:18787411 ATG5 Human sphingosine 1-phosphate multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 3-methyladenine inhibits the reaction [sphingosine 1-phosphate results in increased expression of ATG5 protein] more ... CTD PMID:37169277 ATG5 Human sphingosine 1-phosphate increases expression ISO Atg5 (Rattus norvegicus) 6480464 sphingosine 1-phosphate results in increased expression of ATG5 mRNA and sphingosine 1-phosphate results in increased expression of ATG5 protein CTD PMID:37169277 ATG5 Human stilbenoid decreases response to substance EXP 6480464 ATG5 protein results in decreased susceptibility to Stilbenes CTD PMID:23059970 ATG5 Human streptozocin increases expression ISO Atg5 (Mus musculus) 6480464 Streptozocin results in increased expression of ATG5 mRNA CTD PMID:24889822 ATG5 Human streptozocin multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 [[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in decreased expression of ATG5 mRNA and [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of ATG5 mRNA CTD PMID:35786680 ATG5 Human streptozocin increases expression ISO Atg5 (Rattus norvegicus) 6480464 Streptozocin results in increased expression of ATG5 protein CTD PMID:38706688 ATG5 Human swainsonine increases expression ISO Atg5 (Mus musculus) 6480464 Swainsonine results in increased expression of ATG5 mRNA and Swainsonine results in increased expression of ATG5 protein CTD PMID:36402259 ATG5 Human swainsonine increases expression ISO Atg5 (Rattus norvegicus) 6480464 Swainsonine results in increased expression of ATG5 protein CTD PMID:37442287 ATG5 Human swainsonine multiple interactions ISO Atg5 (Mus musculus) 6480464 [bafilomycin A1 co-treated with Swainsonine] results in increased expression of ATG5 mRNA and [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of ATG5 protein CTD PMID:36402259 ATG5 Human T-2 toxin affects expression ISO Atg5 (Rattus norvegicus) 6480464 T-2 Toxin affects the expression of ATG5 protein CTD PMID:29413859 ATG5 Human T-2 toxin increases expression ISO Atg5 (Mus musculus) 6480464 T-2 Toxin results in increased expression of ATG5 protein CTD PMID:35289972 ATG5 Human T-2 toxin affects expression ISO Atg5 (Mus musculus) 6480464 T-2 Toxin affects the expression of ATG5 protein CTD PMID:36402210 ATG5 Human T-2 toxin multiple interactions ISO Atg5 (Mus musculus) 6480464 3-methyladenine affects the reaction [T-2 Toxin affects the expression of ATG5 protein] CTD PMID:36402210 ATG5 Human temozolomide decreases expression EXP 6480464 Temozolomide results in decreased expression of ATG5 mRNA CTD PMID:31758290 ATG5 Human tert-butyl hydroperoxide decreases expression EXP 6480464 tert-Butylhydroperoxide results in decreased expression of ATG5 mRNA CTD PMID:15336504 ATG5 Human tetrachloromethane multiple interactions ISO Atg5 (Mus musculus) 6480464 [TRP53BP2 protein affects the susceptibility to Carbon Tetrachloride] which affects the expression of ATG5 protein more ... CTD PMID:31513885 and PMID:33549628 ATG5 Human thiacloprid decreases expression ISO Atg5 (Mus musculus) 6480464 thiacloprid results in decreased expression of ATG5 mRNA and thiacloprid results in decreased expression of ATG5 protein CTD PMID:37468076 ATG5 Human thymoquinone decreases expression EXP 6480464 thymoquinone results in decreased expression of ATG5 protein CTD PMID:31298468 ATG5 Human titanium dioxide decreases methylation ISO Atg5 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of ATG5 gene CTD PMID:35295148 ATG5 Human trans-piceid multiple interactions EXP 6480464 polydatin inhibits the reaction [Rotenone results in decreased expression of ATG5 protein] CTD PMID:31926197 ATG5 Human trifluoperazine increases expression EXP 6480464 Trifluoperazine results in increased expression of ATG5 protein CTD PMID:38360085 ATG5 Human Triptolide increases expression ISO Atg5 (Mus musculus) 6480464 triptolide results in increased expression of ATG5 protein CTD PMID:26990902 ATG5 Human trovafloxacin increases expression EXP 6480464 trovafloxacin results in increased expression of ATG5 mRNA CTD PMID:33609687 ATG5 Human trovafloxacin affects response to substance EXP 6480464 ATG5 protein affects the susceptibility to trovafloxacin CTD PMID:33609687 ATG5 Human trovafloxacin multiple interactions EXP 6480464 ATG5 protein affects the reaction [trovafloxacin results in increased cleavage of CASP3 protein] more ... CTD PMID:33609687 ATG5 Human tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of ATG5 protein CTD PMID:36640941 ATG5 Human tunicamycin increases expression ISO Atg5 (Rattus norvegicus) 6480464 Tunicamycin results in increased expression of ATG5 mRNA and Tunicamycin results in increased expression of ATG5 protein CTD PMID:37654027 ATG5 Human tunicamycin multiple interactions ISO Atg5 (Mus musculus) 6480464 [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of ATF4 mRNA more ... CTD PMID:29793971 ATG5 Human tunicamycin increases response to substance ISO Atg5 (Mus musculus) 6480464 ATG5 protein mutant form results in increased susceptibility to Tunicamycin CTD PMID:29793971 ATG5 Human tunicamycin increases expression ISO Atg5 (Mus musculus) 6480464 Tunicamycin results in increased expression of ATG5 mRNA CTD PMID:29793971 ATG5 Human tunicamycin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Tunicamycin results in increased expression of ATG5 protein] CTD PMID:36640941 ATG5 Human tyloxapol decreases expression ISO Atg5 (Mus musculus) 6480464 tyloxapol results in decreased expression of ATG5 protein CTD PMID:36905866 ATG5 Human tyloxapol multiple interactions ISO Atg5 (Mus musculus) 6480464 Escin inhibits the reaction [tyloxapol results in decreased expression of ATG5 protein] CTD PMID:36905866 ATG5 Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of ATG5 mRNA CTD PMID:23527032 ATG5 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of ATG5 mRNA CTD PMID:27188386 ATG5 Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of ATG5 mRNA CTD PMID:23179753 ATG5 Human vitamin E multiple interactions ISO Atg5 (Rattus norvegicus) 6480464 Vitamin E inhibits the reaction [Doxorubicin results in increased expression of ATG5 mRNA] CTD PMID:38997059 ATG5 Human vorinostat multiple interactions EXP 6480464 [sorafenib co-treated with vorinostat] promotes the reaction [FAS protein binds to CASP8 protein binds to ATG5 protein binds to HSPA5 protein] more ... CTD PMID:18787411 and PMID:20543569 ATG5 Human vorinostat increases expression EXP 6480464 vorinostat results in increased expression of ATG5 mRNA CTD PMID:27188386 ATG5 Human zearalenone increases expression ISO Atg5 (Mus musculus) 6480464 Zearalenone results in increased expression of ATG5 mRNA and Zearalenone results in increased expression of ATG5 protein CTD PMID:34537261 ATG5 Human zinc atom multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of ATG5 mRNA CTD PMID:18593933 ATG5 Human zinc oxide increases expression ISO Atg5 (Mus musculus) 6480464 Zinc Oxide analog results in increased expression of ATG5 mRNA CTD PMID:24614525 ATG5 Human zinc oxide increases expression ISO Atg5 (Rattus norvegicus) 6480464 Zinc Oxide results in increased expression of ATG5 mRNA CTD PMID:32951350 ATG5 Human zinc oxide multiple interactions ISO Atg5 (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased expression of ATG5 mRNA] CTD PMID:24614525 ATG5 Human zinc(0) multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of ATG5 mRNA CTD PMID:18593933
